Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about 2 National symposiums are presently dedicated exclusively to Gene patent and about 10 Open Access Articles are being published on Gene patent.
Gene patent is a patent on an invention in the field of biology that by law allows the patent holder to exclude others from making, using, selling, or importing the protected invention for a limited period of time. The scope and reach of biological patents vary among jurisdictions and may include biological technology and products, genetically modified organisms and genetic material. The applicability of patents to substances and processes wholly or partially natural in origin is a subject of debate. The patenting of genes is a controversial issue in terms of bioethics. There are three main concerns voiced about genetic patenting. First, some believe it is unethical to patent genetic material because it treats life as a commodity. Second, some say that living materials occur naturally, and therefore cannot be patented. Finally, there is the fear that allowing patents on genetic material will undermine the dignity of people and other animals by subjecting their genes to ownership by other people. While some feel that a patent on living material is unethical, others believe that not allowing patents on biotechnological inventions would also be unethical.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conferences.
Scope and Importance:
Gene patents are among the most contentious, opaque and poorly understood aspects of modern IP. Inventions and products or services that hinge on knowledge of or direct use of the sequences that make up genetic material, typically DNA, or the proteins that genes encode, are becoming common and very important. Societal concerns about the appropriateness of allowing patenting of these components of living systems have also become prominent.
Market Analysis:
Patent expiry of major drugs is a foremost concern for pharmaceutical companies. Developing a new chemical entity (NCE) is more expensive and time consuming than developing a novel drug delivery technology. Therefore, in recent years many pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs.
List of Best International Conferences:
1. 4th Integrative Biology Conference; July 18-20, 2016 Berlin, Germany
2. 4th Plant Genomics Conference; July 14-15,2016 Brisbane, Australia
3. 10th Asia-Pacific Biotech Conference; July 25-27, 2016 Bangkok, Thailand
4. Genetic Counseling and Genomic Medicine Conference; August 11-12, 2016 Birmingham, UK
5. Synthetic Biology Conference; September 28-30, 2015 Houston, USA
6. Human Genetics Conference; October 31- November 02, 2016 Valencia, Spain
7. Clinical and Molecular Genetics Conference; November 28-30, 2016 Chicago, USA
8. Biomaterials Conference; March 14-16, 2016 London, UK
9. 5th Cell and Gene Therapy Conference; May 19-21, 2016 San Antonio, USA
10. 6th Biotechnology Conference; October 05-07, 2015, New Delhi, India
11. 12th Biotechnology Conference; November 14-15, 2016 San Francisco, USA
12. Veterinary Microbiology Conference; 2016 Sept 15-17, 2016 San Antonio, USA
13. 7th Bioavailability and Bioequivalence Summit; August 29-31, 2016 Atlanta, USA
14. 4th Biologics and Biosimilars Conference ; October 26-28, 2015 Baltimore, USA
15. Drug Formulation and Bioavailability Conference ; June 06-08, 2016 Beijing, China
16. 6th Bioinformatics Conference March 29-30, 2016 Valencia, Spain
17. 7th Bioinformatics conference October 27-28, 2016 Chicago, USA
18. 5th Biodiversity Conference March 10-12, 2016 Madrid, Spain
19. 2nd Biotechnology Transfer & Commercialization Conference 10 - 11 Sep 2015
20. Biomolecular Engineering Conference 05 - 07 Jan 2016, Singapore
21. 4th Biotechnology World Congress 15-18 Feb 2016, Dubai, United Arab Emirates
22. Genome Editing and Gene Modulation Congress 2016 06-08 Apr 2016, United Kingdom
Relevant Society and Associations
1. American Society for Biochemistry and Molecular Biology
2. ASCPT American Society for Clinical Pharmacology and Therapeutics
3. ASGT American Society of Gene Therapy
4. European Association of Pharma Biotechnology
5. European Biopharmaceutical Enterprises
6. European Federation of Pharmaceutical Industries and Associations
7. Japan Bioindustry Association
8. ASMUSA American Society for Microbiology
9. All India Biotech Association
10. Association of Biotechnology Led Enterprises
11. Biotechnology Industry Organization
12. Arab Alliance for the Prudent Use of Antimicrobials
13. Arab Society of Chemotherapy, Microbiology & Infectious Diseases
14. Asia-Pacific Society for Medical Virology
Companies
1. Abbott Laboratories
2. Valeant Pharmaceuticals
3. Johnson & Johnson
4. Novartis
5. Roche
6. Pfizer
7. Merck
8. Novo Nordisk
9. Gilead Sciences
10. Sanofi
11. Eli Lilly & Co
This page will be updated regularly.
This page was last updated on November 22, 2024
